EUCTR2016-002708-17-FR进行中（未招募）1 期
Pharmacokinetic study on echinocandins for patients with septic shock following secondary peritonitis - EPI Study
CHU de NIMES0 个研究点目标入组 24 人开始时间: 2016年12月14日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 24
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study)Septic ShockPeritonitisNCT02805049Centre Hospitalier Universitaire de Nīmes24
进行中（未招募）
不适用
Pharmacokinetics of anidulafungin (Ecalta ®) given intravenously as antifungal prophylaxis to recipients of an allogeneic haematopoietic stem cell transplant following myeloablative chemotherapy or patients receiving intensive chemotherapy for AML-MDS who are at high risk for developing invasive fungal diseasePharmacokinetics of anidulafungin (Ecalta ®) given intravenously as antifungal prophylaxis to recipients of an allogeneic haematopoietic stem cell transplant following myeloablative chemotherapy or patients receiving intensive chemotherapy for AML-MDS who are at high risk for developing invasive fungal diseaseMedDRA version: 9.1Level: LLTClassification code 10017533Term: Fungal infectionMedDRA version: 12.1Level: HLGTClassification code 10024324Term: LeukaemiasEUCTR2010-018752-27-NLRadboud University Nijmegen Medical Centre
已完成
2 期
Pharmacokinetics of anidulafungin (Ecalta ®) given intravenously as antifungal prophylaxis to recipients of an allogeneic haematopoietic stem cell transplant following myeloablative chemotherapy or patients receiving intensive chemotherapy for AML-MDS who are at high risk for developing invasive fungal diseasefungal infectionhematology patients10017528NL-OMON34306niversitair Medisch Centrum Sint Radboud20
已完成
不适用
Pharmacokinetic analysis of sinecathechins ointment 10% (Veregen) by means of Raman micro-spectroscopy in the skin of healthy volunteersgenital warts10047438Condyloma accuminata10040899NL-OMON42887Academisch Medisch Centrum6
进行中（未招募）
不适用
A study to assess the pharmacokinetics of single escalating doses of inhaled GSK961081 DPI (a dual pharmacophore) in healthy subjects (Part 1) and a randomised, double-blind, double dummy, crossover (incomplete block) study to assess the safety, tolerability, pharmacodynamics (pulmonary and systemic) and pharmacokinetics of 14 days dosing with inhaled GSK961081 DPI compared with placebo and tiotropium plus salmeterol in patients with COPD (Part 2).EUCTR2006-006240-63-DEGlaxoSmithKline Research and Development20